Paradeep Phosphates [PARADEEP] vs UPL [UPLPP] Detailed Stock Comparison
Paradeep Phosphates
NSE
Loading...
UPL
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Paradeep Phosphates wins in 9 metrics, UPL wins in 11 metrics, with 0 ties. UPL appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Paradeep Phosphates | UPL | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.86 | 3.00 | UPL |
| Price-to-Book Ratio | 4.50 | 1.63 | UPL |
| Debt-to-Equity Ratio | 106.91 | 105.06 | UPL |
| PEG Ratio | 0.05 | -0.02 | UPL |
| EV/EBITDA | 12.63 | 13.32 | Paradeep Phosphates |
| Profit Margin (TTM) | 5.28% | 0.09% | Paradeep Phosphates |
| Operating Margin (TTM) | 11.43% | 13.51% | UPL |
| EBITDA Margin (TTM) | 11.43% | 13.51% | UPL |
| Return on Equity | 13.53% | 2.01% | Paradeep Phosphates |
| Return on Assets (TTM) | 4.95% | 0.86% | Paradeep Phosphates |
| Free Cash Flow (TTM) | $10.17B | $84.56B | UPL |
| Dividend Yield | 0.30% | 0.69% | UPL |
| 1-Year Return | 167.07% | 104.96% | Paradeep Phosphates |
| Price-to-Sales Ratio (TTM) | 1.20 | 1.38 | Paradeep Phosphates |
| Enterprise Value | $215.00B | $724.61B | UPL |
| EV/Revenue Ratio | 1.42 | 1.61 | Paradeep Phosphates |
| Gross Profit Margin (TTM) | 28.27% | 54.76% | UPL |
| Revenue per Share (TTM) | $184 | $570 | UPL |
| Earnings per Share (Diluted) | $9.82 | $-0.74 | Paradeep Phosphates |
| Beta (Stock Volatility) | -0.16 | 0.83 | Paradeep Phosphates |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Paradeep Phosphates vs UPL Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Paradeep Phosphates | -7.51% | -0.30% | 38.39% | 54.65% | 131.22% | 96.84% |
| UPL | 0.00% | 0.00% | 14.98% | 19.23% | 96.43% | 129.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Paradeep Phosphates | 167.07% | 375.37% | 419.23% | 419.23% | 419.23% | 419.23% |
| UPL | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% | 104.96% |
Performance & Financial Health Analysis: Paradeep Phosphates vs UPL
| Metric | PARADEEP | UPLPP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹183.05B | ₹622.77B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 24,266,811 | 9,889 |
| 90 Day Avg. Volume | 15,241,344 | 6,572 |
| Last Close | ₹210.83 | ₹516.50 |
| 52 Week Range | ₹78.81 - ₹234.39 | ₹216.20 - ₹563.85 |
| % from 52W High | -10.05% | -8.40% |
| All-Time High | ₹234.39 (Jul 29, 2025) | ₹563.85 (Jul 30, 2025) |
| % from All-Time High | -10.05% | -8.40% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.58% | 0.10% |
| Quarterly Earnings Growth | 46.56% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.00% |
| Operating Margin (TTM) | 0.11% | 0.14% |
| Return on Equity (TTM) | 0.14% | 0.02% |
| Debt to Equity (MRQ) | 106.91 | 105.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹49.91 | ₹318.92 |
| Cash per Share (MRQ) | ₹14.40 | ₹51.99 |
| Operating Cash Flow (TTM) | ₹7.29B | ₹70.93B |
| Levered Free Cash Flow (TTM) | ₹5.52B | ₹7.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.30% | 0.69% |
| Last 12-Month Dividend | ₹0.50 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Paradeep Phosphates vs UPL
| Metric | PARADEEP | UPLPP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.86 | 3.00 |
| Forward P/E | 20.35 | N/A |
| PEG Ratio | 0.05 | -0.02 |
| Price to Sales (TTM) | 1.20 | 1.38 |
| Price to Book (MRQ) | 4.50 | 1.63 |
| Market Capitalization | ||
| Market Capitalization | ₹183.05B | ₹622.77B |
| Enterprise Value | ₹215.00B | ₹724.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.42 | 1.61 |
| Enterprise to EBITDA | 12.63 | 13.32 |
| Risk & Other Metrics | ||
| Beta | -0.16 | 0.83 |
| Book Value per Share (MRQ) | ₹49.91 | ₹318.92 |
Financial Statements Comparison: Paradeep Phosphates vs UPL
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PARADEEP | UPLPP |
|---|---|---|
| Revenue/Sales | ₹34.94B | ₹92.16B |
| Cost of Goods Sold | ₹25.12B | ₹41.69B |
| Gross Profit | ₹9.82B | ₹50.47B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹2.84B | ₹7.64B |
| EBITDA | ₹3.89B | ₹14.78B |
| Pre-Tax Income | ₹2.23B | ₹-1.90B |
| Income Tax | ₹629.40M | ₹-140.00M |
| Net Income (Profit) | ₹1.60B | ₹-1.76B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PARADEEP | UPLPP |
|---|---|---|
| Cash & Equivalents | ₹8.74B | ₹94.78B |
| Total Current Assets | ₹71.24B | ₹396.61B |
| Total Current Liabilities | ₹62.26B | ₹285.69B |
| Long-Term Debt | ₹6.38B | ₹192.56B |
| Total Shareholders Equity | ₹40.77B | ₹378.26B |
| Retained Earnings | N/A | ₹208.68B |
| Property, Plant & Equipment | ₹32.88B | ₹94.31B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PARADEEP | UPLPP |
|---|---|---|
| Operating Cash Flow | ₹-2.08B | N/A |
| Capital Expenditures | ₹-514.75M | N/A |
| Free Cash Flow | ₹-2.31B | N/A |
| Debt Repayment | ₹-19.32B | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PARADEEP | UPLPP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 24,266,811 | 9,889 |
| Average Daily Volume (90 Day) | 15,241,344 | 6,572 |
| Shares Outstanding | 815.21M | 844.43M |
| Float Shares | 358.09M | 563.84M |
| % Held by Insiders | 0.56% | 0.00% |
| % Held by Institutions | 0.27% | 0.17% |
Dividend Analysis & Yield Comparison: Paradeep Phosphates vs UPL
| Metric | PARADEEP | UPLPP |
|---|---|---|
| Last 12-Month Dividend | ₹0.50 | ₹3.00 |
| Last 12-Month Dividend Yield | 0.30% | 0.69% |
| 3-Year Avg Annual Dividend | ₹0.33 | ₹1.00 |
| 3-Year Avg Dividend Yield | 0.66% | 0.69% |
| 3-Year Total Dividends | ₹1.00 | ₹3.00 |
| Ex-Dividend Date | Sep 17, 2024 | Jul 11, 2025 |